Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with lewy bodies in Japan

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 3, 2006, Pages 216-222

  Akatsu, Hiroyasu ^a,b   Yamagata, Hidehisa D ^b   Kawamata, Jun ^c   Kamino, Kouzin ^d   Takeda, Masatoshi ^d   Yamamoto, Takayuki ^a   Miki, Tetsuro ^b   Tooyama, Ikuo ^e   Shimohama, Shun ^c   Kosaka, Kenji ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; Dementia with Lewy bodies; Parkinson's disease; Single nucleotide polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; AUTOPSY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE BANKS; VARIATION (GENETICS);

EID: 33748140773     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094933     Document Type: Article

References (46)

1. Hofer M, Pagliusi SR, Hohn A, et al: Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990;9:2459-2464.
2. Murer MG, Yan Q, Raisman-Vozari R: Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001;63:71-124.
3. Phillips HS, Hains JM, Armanini M, et al: BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991;7:695-702.
4. Connor B, Young D, Yan Q, et al: Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997;49:71-81.
5. Hock C, Heese K, Hulette C, et al: Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000;57:846-851.
6. Michalski B, Fahnestock M: Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 2003;111:148-154.
7. Ventriglia M, Bocchio Chiavetto L, Benussi L, et al: Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002;7:136-137.
8. Egan MF, Kojima M, Callicott JH, et al: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
9. Hariri AR, Goldberg TE, Mattay VS, et al: Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003;23:6690-6694.
10. Nacmias B, Piccini C, Bagnoli S, et al: Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 2004;367:379-383.
11. Tsai SJ, Hong CJ, Liu HC, et al: Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 2004;49:10-12.
12. Combarros O, Infante J, Llorca J, et al: Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2004;18:55-58.
13. Kunugi H, Ueki A, Otsuka M, et al: A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001;6:83-86.
14. Riemenschneider M, Schwarz S, Wagenpfeil S, et al: A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol Psychiatry 2002;7:782-785.
15. Nishimura AL, Oliveira JR, Mitne-Neto M, et al: Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J Mol Neurosci 2004;22:257-260.
16. Bagnoli S, Nacmias B, Tedde A, et al: Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann Neurol 2004;55:447-448.
17. Hyman C, Hofer M, Barde YA, et al: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350:230-232.
18. Howells DW, Porritt MJ, Wong JY, et al: Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 2000;166:127-135.
19. Mogi M, Togari A, Kondo T, et al: Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett 1999;270:45-48.
20. Parain K, Murer MG, Yan Q, et al: Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 1999;10:557-561.
21. Knott C, Stern G, Kingsbury A, et al: Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra. Parkinsonism Relat Disord 2002;8:329-341.
22. Dawson TM, Dawson VL: Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 2003;111:145-151.
23. Momose Y, Murata M, Kobayashi K, et al: Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002;51:133-136.
24. Toda T, Momose Y, Murata M, et al: Toward identification of susceptibility genes for sporadic Parkinson's disease. J Neurol 2003;250(Suppl 3):III40-III43.
25. Hakansson A, Melke J, Westberg L, et al: Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population. Ann Neurol 2003;53:823.
26. Hong CJ, Liu HC, Liu TY, et al: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset. Neurosci Lett 2003;353:75-77.
27. Masaki T, Matsushita S, Arai H, et al: Association between a polymorphism of brain-derived neurotrophic factor gene and sporadic Parkinson's disease. Ann Neurol 2003;54:276-277.
28. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
29. Hasegawa K, Inoue K, Moriya K: An investigation of dementia rating scale for the elderly (in Japanese). Seishin Igaku 1974;16:968-969.
30. Katoh S, Shimogaki H, Onodera A, et al: Development of the revised version of Hasegawa's dementia scale (HDS-R) (in Japanese). Jpn J Geriatr Psychiatry 1991;2:1339-1347.
31. Akatsu H, Yamagata H, Chen Y, et al: TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction. Br J Haematol 2004;127:440-447.
32. Akatsu H, Kamino K, Yamagata H, et al: Increased incidence of dementia with Lewy bodies in patients carrying the ε4-allele of apolipoprotein E. Psychogeriatrics 2004;4:24-32.
33. Haga C, Ikeda K, Iwabuchi K, et al: Methenamine-silver staining: a simple and sensitive staining method for senile plaques and neurofibrillary tangles. Biotech Histochem 1994;69:295-300.
34. Mölsa PK, Paljärvi L, Rinne JO, et al: Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
35. Akatsu H, Takahashi M, Matsukawa N, et al: Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 2002;196:63-69.
36. Kosaka K, Iseki E, Arai H: Recent advances in dementia research in Japan: Alzheimer-type dementia. Psychiatry Clin Neurosci 1999;53:1-10.
37. Kosaka K, Iseki E: Recent advances in dementia research in Japan: non-Alzheimer-type degenerative dementias. Psychiatry Clin Neurosci 1998;52:367-373.
38. Kosaka K, Iseki E, Odawara T: Limbic neurofibrillary tangle dementia (abstract). Brain Pathol 1997;7:1114.
39. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
40. Kosaka K: Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
41. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
42. Guillin O, Diaz J, Carroll P, et al: BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001;411:86-89.
43. Shimizu E, Hashimoto K, Iyo M: Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004;126:122-123.
44. Desai P, Nebes R, DeKosky ST, et al: Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci Lett 2005;379:229-234.
45. Saito Y, Ruberu NN, Sawabe M, et al: Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 2004;63:742-749.
46. Dluzen DE, McDermott JL, Anderson LI, et al: Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice. Neuroscience 2004;128:201-208.